ATRIAL FIBRILATION (AF) - CORONARY ARTERY (CAD) - INTRACRANIAL ANEURYSM (IA) -PEREPHERIC ARTERY DISEASE (PAD) - VENOUS THROMBOEMBOLISM (VTE) - ROMATOID ARTHRITIS AND ACE (ANGIOTENCIN 1 CONVERTING ENZYGLINE) 14 CONVERTING ENZYGLINE ANALYSIS.

 

GENES ANALYZED;

4q25 / PITX2 / LPA / CDKN2B-AS1 / CDKN2B-AS1 (rs2383206) / CDKN2B-AS1 (rs2383207) / LPA (rs3798220) / LPA (rs10958409) / CDKN2A / CDKN2B / CHRNA5 /

 

With the Genetic Passport® Cardiac Panel, it is now possible to detect many genetically based cardiovascular system disease risks from the moment a human is born. Risks can be minimized or eliminated by regulating environmental conditions in accordance with genetic structure, exercise and diet programs appropriate to genetic structure.

GENETIC PASSPORT® CARDIOLOGIC

599,00$Fiyat
    • Facebook
    • Instagram
    • YouTube
    • Pinterest

                      Genetic Trainer® System is a registered innovation. Genetic Trainer courses can only be organized by institutes authorized by Genetic Trainer.

             Genetic Trainer® / GT. Academy® / GT. Studio® are trademarks of Genetic Trainer Corporation in the U.S. and/or other countries. All Rights Reserved

      © COPYRIGHT 2019 GENETIC TRAINER CORP.